{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:50:22Z","timestamp":1785354622388,"version":"3.55.0"},"reference-count":175,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.clinbiochem.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,7]],"date-time":"2016-05-07T12:53:57Z","timestamp":1462625637000},"page":"1009-1023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["LC\u2013MS\/MS as a tool for TDM services: Where are we?"],"prefix":"10.1016","volume":"49","author":[{"given":"Maria","family":"Shipkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobrin","family":"Svinarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1373\/clinchem.2015.251272","article-title":"Clinical mass spectrometry-achieving prominence in laboratory medicine","volume":"62","author":"Annesley","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1373\/clinchem.2015.239475","article-title":"Mass spectrometry in precision medicine: phenotypic measurements alongside pharmacogenomics","volume":"62","author":"Clarke","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clinbiochem.2010.08.018","article-title":"HPLC-high resolution mass spectrometry in clinical laboratory?","volume":"44","author":"Jiwan","year":"2011","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0020","doi-asserted-by":"crossref","first-page":"D1","DOI":"10.1530\/EJE-15-0338","article-title":"Mass spectrometry and immunoassay; how to measure steroid hormones today and tomorrow","volume":"173","author":"Taylor","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0025","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1373\/clinchem.2009.138602","article-title":"Pitfalls associated with the use of liquid chromatography\u2013tandem mass spectrometry in the clinical laboratory","volume":"56","author":"Vogeser","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clinbiochem.2010.06.005","article-title":"Progress in automation of LC\u2013MS in laboratory medicine","volume":"44","author":"Vogeser","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2011.09.041","article-title":"Therapeutic drug monitoring and LC\u2013MS\/MS","volume":"883\u2013884","author":"Adaway","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0040","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00216-007-1320-1","article-title":"Current role of LC\u2013MS in therapeutic drug monitoring","volume":"388","author":"Saint-Marcoux","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0045","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.clinbiochem.2013.08.013","article-title":"Immunosuppressant therapeutic drug monitoring by LC\u2013MS\/MS: workflow optimization through automated processing of whole blood samples","volume":"46","author":"Marinova","year":"2013","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/rcm.246","article-title":"Rapid bioanalysis of vancomycin in serum and urine by high-performance liquid chromatography tandem mass spectrometry using on-line sample extraction and parallel analytical columns","volume":"15","author":"Cass","year":"2001","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/FTD.0000000000000120","article-title":"Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography\u2013tandem mass spectrometry","volume":"37","author":"Peake","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jchromb.2015.08.025","article-title":"Development and validation of a turbulent flow chromatography and tandem mass spectrometry method for the quantitation of methotrexate and its metabolites 7-hydroxy methotrexate and DAMPA in serum","volume":"1002","author":"Schofield","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00216-012-6176-3","article-title":"An automated method for the simultaneous measurement of azole antifungal drugs in human plasma or serum using turbulent flow liquid chromatography\u2013tandem mass spectrometry","volume":"404","author":"Couchman","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2012.04.006","article-title":"Determination of four immunosuppressive drugs in whole blood using MEPS and LC\u2013MS\/MS allowing automated sample work-up and analysis","volume":"897","author":"Said","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chroma.2014.02.037","article-title":"Development of microextraction by packed sorbent for toxicological analysis of tricyclic antidepressant drugs in human oral fluid","volume":"1337","author":"Wo\u017aniakiewicz","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.talanta.2015.03.032","article-title":"Hybrid silica monolith for microextraction by packed sorbent to determine drugs from plasma samples by liquid chromatography\u2013tandem mass spectrometry","volume":"140","author":"de Souza","year":"2015","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.clinbiochem.2016.05.001_bb0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/FTD.0000000000000139","article-title":"Performance of the new RapidFire system for therapeutic monitoring of immunosuppressants","volume":"37","author":"Grote-Koska","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.aca.2013.10.051","article-title":"Ultra-fast cyclosporin A quantitation in whole blood by laser diode thermal desorption-tandem mass spectrometry; comparison with high performance liquid chromatography\u2013tandem mass spectrometry","volume":"805","author":"Jourdil","year":"2013","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1373\/clinchem.2015.245191","article-title":"Rapid measurement of cyclosporine and sirolimus in whole blood by paper spray-tandem mass spectrometry","volume":"62","author":"Shi","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2014.12.022","article-title":"Rapid measurement of tacrolimus in whole blood by paper spray-tandem mass spectrometry (PS-MS\/MS)","volume":"441","author":"Shi","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1373\/clinchem.2014.237164","article-title":"Ambient ionization mass spectrometry for point-of-care diagnostics and other clinical measurements","volume":"62","author":"Ferreira","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0004563214557678","article-title":"Liquid chromatography tandem mass spectrometry in the clinical laboratory","volume":"52","author":"Adaway","year":"2015","journal-title":"Ann. Clin. Biochem."},{"issue":"12","key":"10.1016\/j.clinbiochem.2016.05.001_bb0115","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1128\/AAC.00404-10","volume":"54","author":"Decosterd","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0120","first-page":"85","article-title":"Multiplex mass spectrometry analysis of latest-generation antiepileptic drugs: a clinically useful laboratory tool for improved real-time patients' care","volume":"32","author":"Decosterd","year":"2015","journal-title":"Epileptologie"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1373\/clinchem.2015.248146","article-title":"Effective use of mass spectrometry in the clinical laboratory","volume":"62","author":"Jannetto","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0130","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1515\/CCLM.2002.172","article-title":"Clinical utility of free drug monitoring","volume":"40","author":"Dasgupta","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","article-title":"Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management","volume":"377","author":"Dasgupta","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0140","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4155\/bio.15.35","article-title":"Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC\u2013MS\/MS","volume":"7","author":"Ghareeb","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpba.2015.06.005","article-title":"Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry","volume":"114","author":"Yamada","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cca.2014.12.008","article-title":"Advances in detection of antipsychotics in biological matrices","volume":"441","author":"Patteet","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0155","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1128\/AAC.03636-14","article-title":"Clinical validation of the analysis of fluconazole in oral fluid in hospitalized children","volume":"58","author":"van der Elst","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.talanta.2014.10.041","article-title":"A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC\u2013MS\/MS","volume":"134","author":"Berm","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.talanta.2013.12.043","article-title":"Simultaneous determination of rifampicin, clarithromycin and theirmetabolites in dried blood spots using LC\u2013MS\/MS","volume":"121","author":"Vu","year":"2014","journal-title":"Talanta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinbiochem.2010.06.014","article-title":"The analysis of dried blood spot samples using liquid chromatography tandem mass spectrometry","volume":"44","author":"Keevil","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0180","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1309\/AJCP1L7DKMPCHPEH","article-title":"Drop-to-drop variation in the cellular components of fingerprick blood: implications for point-of-care diagnostic development","volume":"144","author":"Bond","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2016.05.001_bb0185","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cllc.2014.12.012","article-title":"Concentrations of erlotinib in tumor tissue and plasma in non-small-cell lung cancer patients after neoadjuvant therapy","volume":"16","author":"Lankheet","year":"2015","journal-title":"Clin. Lung Cancer"},{"issue":"3","key":"10.1016\/j.clinbiochem.2016.05.001_bb0190","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/FTD.0b013e31805c73f1","article-title":"Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection","volume":"29","author":"Capron","year":"2007","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.phrs.2013.06.003","article-title":"Opportunity to monitor immunosuppressive drugs in peripheral blood mononuclear cells: where are we and where are we going?","volume":"74","author":"Lemaitre","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/CAD.0000000000000069","article-title":"Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells","volume":"25","author":"Berglund","year":"2014","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpba.2015.02.051","article-title":"Development of an LC\u2013MS\/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil","volume":"110","author":"Derissen","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jchromb.2014.01.021","article-title":"A sensitive LC\u2013MS\/MS method for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells","volume":"964","author":"Tu","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0215","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s00216-015-8554-0","article-title":"Liquid chromatography tandem mass spectrometry quantitation of intracellular concentrations of ganciclovir and its phosphorylated forms","volume":"407","author":"Billat","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1373\/clinchem.2013.213264","article-title":"Calcineurin activity assay measurement by liquid chromatography\u2013tandem mass spectrometry in the multiple reaction monitoring mode","volume":"60","author":"Carr","year":"2014","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0225","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/FTD.0b013e3182a13900","article-title":"Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC\u2013MS\/MS: assessment of biomarker responses to mycophenolic acid","volume":"36","author":"Vethe","year":"2014","journal-title":"Ther. Drug Monit."},{"issue":"8","key":"10.1016\/j.clinbiochem.2016.05.001_bb0230","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1074\/mcp.O115.050351","article-title":"Peptide immunoaffinity enrichment and targeted mass spectrometry enables multiplex, quantitative pharmacodynamic studies of phospho-signaling","volume":"14","author":"Whiteaker","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"issue":"13","key":"10.1016\/j.clinbiochem.2016.05.001_bb0235","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1021\/ac1008628","article-title":"LC\u2013MS\/MS coupled with stable isotope dilution method for the quantification of 6-thioguanine and S 6-methylthioguanine in genomic DNA of human cancer cells treated with 6-thioguanine","volume":"82","author":"Wang","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jchromb.2011.11.032","article-title":"Liquid chromatography\u2013tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standard","volume":"881\u2013882","author":"Jacobsen","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0245","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.talanta.2014.07.087","article-title":"Simultaneous pharmacokinetic and pharmacodynamic analysis of 5\u03b1-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry","volume":"131","author":"Upreti","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0250","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clinbiochem.2015.10.001","article-title":"Drug target molecules to guide immunosuppression","volume":"49","author":"Bergan","year":"2016","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0255","first-page":"333","article-title":"Biomarkers in blood for individualization of the pharmacotherapy with immunosuppressive drugs after transplantation of solid organs","volume":"38","author":"Wieland","year":"2014","journal-title":"J. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0260","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1373\/clinchem.2015.239285","article-title":"Potential of mass spectrometry in developing clinical laboratory biomarkers of nonvolatiles in exhaled breath","volume":"62","author":"Beck","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0265","article-title":"Liquid chromatography tandem mass spectrometry for therapeutic drug monitoring of immunosuppressive drugs: achievements, lessons and open issues","author":"Shipkova","year":"2016","journal-title":"TRAC"},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0270","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jpba.2007.02.006","article-title":"Recent advances in high-throughput quantitative bioanalysis by LC\u2013MS\/MS","volume":"44","author":"Xu","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0275","series-title":"CLSI document C62-A","article-title":"Liquid Chromatography-Mass Spectrometry Methods; Approved Guideline","author":"CLSI","year":"2014"},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/bmc.3356","article-title":"Stereo-specific LC and LC\u2013MS bioassays of antidepressants and psychotics","volume":"29","author":"Nageswara Rao","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0285","article-title":"Hydrophilic interaction liquid chromatography\/mass spectrometry: an attractive and prospective method for the quantitative bioanalysis in drug metabolism","author":"Li","year":"2015","journal-title":"Curr. Drug Metab."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0290","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/dta.1337","article-title":"The analysis of antipsychotic drugs in human matrices using LC\u2013MS(\/MS)","volume":"4","author":"Saar","year":"2012","journal-title":"Drug Test Anal."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0295","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2006.05.031","article-title":"Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach","volume":"843","author":"Kirchherr","year":"2006","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jchromb.2004.03.079","article-title":"Quantitative analysis of 33 benzodiazepines, metabolites and benzodiazepine-like substances in whole blood by liquid chromatography-(tandem) mass spectrometry","volume":"811","author":"Smink","year":"2004","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"9","key":"10.1016\/j.clinbiochem.2016.05.001_bb0305","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1373\/clinchem.2008.105478","article-title":"Pitfalls and prevention strategies for liquid chromatography\u2013tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis","volume":"54","author":"Sauvage","year":"2008","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0310","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clinbiochem.2010.06.012","article-title":"The current role of liquid chromatography\u2013tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs","volume":"44","author":"Taylor","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0315","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000000269","article-title":"Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice: Recommendations of the IATDMCT Immunosuppressive Drugs Scientific Committee","author":"Seger","year":"2016","journal-title":"Ther. Drug Monit."},{"issue":"23","key":"10.1016\/j.clinbiochem.2016.05.001_bb0320","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jchromb.2009.01.003","article-title":"Validation of bioanalytical LC\u2013MS\/MS assays: evaluation of matrix effects","volume":"877","author":"Van Eeckhaut","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.talanta.2013.03.048","article-title":"Ion suppression; a critical review on causes, evaluation, prevention and applications","volume":"115","author":"Furey","year":"2013","journal-title":"Talanta"},{"issue":"10","key":"10.1016\/j.clinbiochem.2016.05.001_bb0330","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1373\/clinchem.2007.090811","article-title":"Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry","volume":"53","author":"Annesley","year":"2007","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0335","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1373\/clinchem.2004.043992","article-title":"Application of commercial calibrators for the analysis of immunosuppressant drugs in whole blood","volume":"51","author":"Annesley","year":"2005","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.clinbiochem.2016.05.001_bb0340","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4155\/bio.11.93","article-title":"Challenges of developing a bioanalytical method for a macrolide immunosuppressant compound by LC\u2013MS\/MS","volume":"3","author":"Taillon","year":"2011","journal-title":"Bioanalysis"},{"issue":"8","key":"10.1016\/j.clinbiochem.2016.05.001_bb0345","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1373\/clinchem.2008.105643","article-title":"Instrument-specific matrix effects of calibration materials in the LC\u2013MS\/MS analysis of tacrolimus","volume":"54","author":"Vogeser","year":"2008","journal-title":"Clin. Chem."},{"issue":"Pt 3","key":"10.1016\/j.clinbiochem.2016.05.001_bb0350","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0004563213478938","article-title":"Potential problems with using deuterated internal standards for liquid chromatography\u2013tandem mass spectrometry","volume":"50","author":"Davison","year":"2013","journal-title":"Ann. Clin. Biochem."},{"issue":"13","key":"10.1016\/j.clinbiochem.2016.05.001_bb0355","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/rcm.4587","article-title":"Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography\/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples","volume":"24","author":"Furlong","year":"2010","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"13","key":"10.1016\/j.clinbiochem.2016.05.001_bb0360","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/rcm.3577","article-title":"Isobaric metabolite interferences and the requirement for close examination of raw data in addition to stringent chromatographic separations in liquid chromatography\/tandem mass spectrometric analysis of drugs in biological matrix","volume":"22","author":"Yan","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"23\u201324","key":"10.1016\/j.clinbiochem.2016.05.001_bb0365","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cca.2011.07.016","article-title":"LC\u2013MS\/MS quantitation of ribavirin in serum and identification of endogenous isobaric interferences","volume":"412","author":"Danso","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.clinbiochem.2016.05.001_bb0370","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jssc.201301173","article-title":"Quantitation of ribavirin in human plasma and red blood cells using LC\u2013MS\/MS","volume":"37","author":"Ferreir\u00f3s","year":"2014","journal-title":"J. Sep. Sci."},{"issue":"19","key":"10.1016\/j.clinbiochem.2016.05.001_bb0375","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/1097-0231(20001015)14:19<1757::AID-RCM90>3.0.CO;2-C","article-title":"The need for chromatographic and mass resolution in liquid chromatography\/tandem mass spectrometric methods used for quantitation of lactones and corresponding hydroxy acids in biological samples","volume":"14","author":"Jemal","year":"2000","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0380","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00007691-200112000-00021","article-title":"Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum","volume":"23","author":"Vogeser","year":"2001","journal-title":"Ther. Drug Monit."},{"issue":"12","key":"10.1016\/j.clinbiochem.2016.05.001_bb0385","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1515\/CCLM.2010.333","article-title":"Impact of glucuronide interferences on therapeutic drug monitoring of posaconazole by tandem mass spectrometry","volume":"48","author":"Kr\u00fcger","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"issue":"11","key":"10.1016\/j.clinbiochem.2016.05.001_bb0390","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1373\/clinchem.2013.209114","article-title":"Standardization of LC\u2013MS for therapeutic drug monitoring of tacrolimus","volume":"59","author":"Annesley","year":"2013","journal-title":"Clin. Chem."},{"issue":"12","key":"10.1016\/j.clinbiochem.2016.05.001_bb0395","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1373\/clinchem.2011.172080","article-title":"The need for standardization of tacrolimus assays","volume":"57","author":"Levine","year":"2011","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0400","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FTD.0b013e318274827d","article-title":"Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography\u2013tandem mass spectrometric assay","volume":"35","author":"Becker","year":"2013","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0405","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/QCO.0000000000000206","article-title":"Optimizing dosing of antibiotics in critically ill patients","volume":"28","author":"Parker","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0410","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2011.04080.x","article-title":"Therapeutic drug monitoring of antimicrobials","volume":"73","author":"Roberts","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0415","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpba.2013.08.002","article-title":"Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC\u2013MS\/MS technology","volume":"86","author":"Djerada","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0420","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s00216-010-3986-z","article-title":"Therapeutic drug monitoring by LC\u2013MS-MS with special focus on anti-infective drugs","volume":"398","author":"M\u00fcller","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpba.2014.08.026","article-title":"Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"102","author":"Kim","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.clinbiochem.2016.05.001_bb0430","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/bmc.3330","article-title":"Recent bioanalytical methods for quantification of third-generation cephalosporins using HPLC and LC\u2013MS(\/MS) and their applications in pharmacokinetic studies","volume":"28","author":"Jin","year":"2014","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0435","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/mas.20189","article-title":"Analysis of macrolide antibiotics, using liquid chromatography-mass spectrometry, in food, biological and environmental matrices","volume":"28","author":"Wang","year":"2009","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0440","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpba.2012.04.007","article-title":"Rapid and sensitive LC-MS\/MS method for the analysis of antibiotic linezolid on dried blood spot","volume":"67\u201368","author":"la Marca","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0445","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jpba.2011.12.018","article-title":"Development of an UPLC-MS\/MS method for the determination of antibiotic ertapenem on dried blood spots","volume":"61","author":"la Marca","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.clinbiochem.2016.05.001_bb0450","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jpba.2010.10.011","article-title":"A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation","volume":"54","author":"D'Avolio","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2015.10.008","article-title":"Simultaneous determination of ceftaroline, daptomycin, linezolid and rifampicin concentrations in human plasma by on-line solid phase extraction coupled to high-performance liquid chromatography\u2013tandem mass spectrometry","author":"Gr\u00e9goire","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.clinbiochem.2016.05.001_bb0460","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1515\/cclm-2013-0594","article-title":"Quantification of linezolid in serum by LC\u2013MS\/MS using semi-automated sample preparation and isotope dilution internal standardization","volume":"52","author":"Zander","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"issue":"19","key":"10.1016\/j.clinbiochem.2016.05.001_bb0465","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1007\/s00216-013-7049-0","article-title":"Development and validation of a hydrophilic interaction liquid chromatography\u2013tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma","volume":"405","author":"Zhou","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0470","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpba.2013.04.015","article-title":"Hydrophilic interaction chromatography (HILIC) in the analysis of antibiotics","volume":"87","author":"Kahsay","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0475","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.talanta.2012.10.046","article-title":"Development and validation of a fast and uniform approach to quantify \u03b2-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry","volume":"103","author":"Colin","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0480","first-page":"8","article-title":"A simple quantitative method analysing amikacin, gentamicin, and vancomycin levels in human newborn plasma using ion-pair liquid chromatography\/tandem mass spectrometry and its applicability to a clinical study","volume":"951\u2013952","author":"Bijleveld","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0485","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchromb.2014.04.029","article-title":"Simultaneous determination of seven \u03b2-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies","volume":"960","author":"Sime","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2012.12.028","article-title":"Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography\u2013tandem mass spectrometry","volume":"919\u2013920","author":"Jourdil","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0495","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpba.2015.01.027","article-title":"Multiplexed LC\u2013MS\/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma","volume":"107","author":"Jiang","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0500","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.talanta.2013.02.010","article-title":"Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"110","author":"Kuhn","year":"2013","journal-title":"Talanta"},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0505","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/rcm.2821","article-title":"The accuracy of oxcarbazepine (OXC) quantification by a liquid chromatography\/tandem mass spectrometry method is influenced by the ion source fragmentation of its metabolite trans-diol-carbazepine (DHD)","volume":"21","author":"Corso","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0510","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/FTD.0b013e3182425168","article-title":"High-performance liquid chromatography\u2013tandem mass spectrometry method for simultaneous quantification of carbamazepine, oxcarbazepine, and their main metabolites in human serum","volume":"34","author":"Lionetto","year":"2012","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.clinbiochem.2016.05.001_bb0515","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpba.2011.07.019","article-title":"Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"56","author":"Kim","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0520","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00216-011-5251-5","article-title":"Development and validation of a reference measurement procedure for certification of phenytoin, phenobarbital, lamotrigine, and topiramate in human serum using isotope-dilution liquid chromatography\/tandem mass spectrometry","volume":"401","author":"Tai","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"issue":"12","key":"10.1016\/j.clinbiochem.2016.05.001_bb0525","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/bmc.1598","article-title":"Analyses of benzodiazepines and their metabolites in various biological matrices by LC\u2013MS(\/MS)","volume":"25","author":"Nakamura","year":"2011","journal-title":"Biomed. Chromatogr."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0530","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0535","article-title":"Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology","author":"Hiemke","year":"2015","journal-title":"Curr. Drug Deliv."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0540","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.ftd.0000194026.04483.c3","article-title":"A fully automated turbulent-flow liquid chromatography\u2013tandem mass spectrometry technique for monitoring antidepressants in human serum","volume":"28","author":"Sauvage","year":"2006","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0545","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchromb.2010.11.024","article-title":"Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography\u2013tandem mass spectrometry","volume":"879","author":"Hasselstr\u00f8m","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.clinbiochem.2016.05.001_bb0550","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/FTD.0000000000000197","article-title":"Simple and accurate quantitative analysis of 16 antipsychotics and antidepressants in human plasma by ultrafast high-performance liquid chromatography\/tandem mass spectrometry","volume":"37","author":"Wang","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0555","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2013.11.024","article-title":"High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography\u2013tandem mass spectrometry","volume":"429","author":"Patteet","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0560","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpba.2008.05.024","article-title":"LC\u2013MS\/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices","volume":"48","author":"de Castro","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0565","first-page":"30","article-title":"Simultaneous quantification of selective serotonin reuptake inhibitors and metabolites in human plasma by liquid chromatography-electrospray mass spectrometry for therapeutic drug monitoring","volume":"885\u2013886","author":"Ansermot","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0570","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cca.2013.04.014","article-title":"Simultaneous UPLC-MS\/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma","volume":"423","author":"Juenke","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0575","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpba.2013.07.041","article-title":"Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring","volume":"88","author":"Gradinaru","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11\u201312","key":"10.1016\/j.clinbiochem.2016.05.001_bb0580","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cca.2010.02.067","article-title":"A rapid and fully-automated method for the quantitation of tricyclic antidepressants in serum using turbulent-flow liquid chromatography\u2013tandem mass spectrometry","volume":"411","author":"Breaud","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0585","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.chroma.2012.12.071","article-title":"Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring","volume":"1292","author":"Ansermot","year":"2013","journal-title":"J. Chromatogr. A"},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0590","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/15563650500514434","article-title":"Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine","volume":"44","author":"Allen","year":"2006","journal-title":"Clin. Toxicol. (Phila)"},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0595","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FTD.0000000000000242","article-title":"Determination of Common Antipsychotics in Quantisal-Collected Oral Fluid by UHPLC\u2013MS\/MS: Method Validation and Applicability for Therapeutic Drug Monitoring","volume":"38","author":"Patteet","year":"2016","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0600","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/FTD.0000000000000205","article-title":"The Impact of Laboratory Practices on Inter-laboratory Variability in Therapeutic Drug Monitoring of Immunosuppressive Drugs","volume":"37","author":"Christians","year":"2015","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0605","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4155\/bio.10.58","article-title":"LC\u2013MS\/MS for immunosuppressant therapeutic drug monitoring","volume":"2","author":"Sallustio","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0610","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.talanta.2013.04.027","article-title":"Fast LC\u2013MS\/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery","volume":"115","author":"Koster","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0615","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cca.2013.02.009","article-title":"Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC\u2013MS\/MS","volume":"421","author":"Sadilkova","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0620","article-title":"Quantification of the immunosuppressant tacrolimus on dried blood spots using LC\u2013MS\/MS","volume":"105","author":"Shokati","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0625","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00216-014-8415-2","article-title":"Dried blood spot analysis of creatinine with LC\u2013MS\/MS in addition to immunosuppressants analysis","volume":"407","author":"Koster","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"10","key":"10.1016\/j.clinbiochem.2016.05.001_bb0630","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1373\/clinchem.2005.055160","article-title":"Evaluation of 3 internal standards for the measurement of cyclosporin by HPLC-mass spectrometry","volume":"51","author":"Taylor","year":"2005","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.clinbiochem.2016.05.001_bb0635","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1515\/CCLM.2005.072","article-title":"Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography\u2013tandem mass spectrometry","volume":"43","author":"Vogeser","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0640","first-page":"61","article-title":"Review of the newest HPLC methods with mass spectrometry detection for determination of immunosuppressive drugs in clinical practice","volume":"14","author":"Korecka","year":"2009","journal-title":"Ann. Transplant."},{"issue":"12","key":"10.1016\/j.clinbiochem.2016.05.001_bb0645","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ejca.2014.04.014","article-title":"Review of therapeutic drug monitoring of anticancer drugs part 1\u2014cytotoxics","volume":"50","author":"Paci","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.clinbiochem.2016.05.001_bb0650","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.ejca.2014.04.013","article-title":"Therapeutic drug monitoring in cancer\u2014are we missing a trick?","volume":"50","author":"Bardin","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.clinbiochem.2016.05.001_bb0655","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.ejca.2014.04.015","article-title":"Review of therapeutic drug monitoring of anticancer drugs part two\u2014targeted therapies","volume":"50","author":"Widmer","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0660","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.dmpk.2015.09.002","article-title":"Routine therapeutic drug monitoring of tyrosine kinase inhibitors by HPLC-UV or LC\u2013MS\/MS methods","volume":"31","author":"Miura","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0665","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2013.08.013","article-title":"A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry","volume":"937","author":"van Erp","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"15\u201316","key":"10.1016\/j.clinbiochem.2016.05.001_bb0670","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jchromb.2010.03.010","article-title":"Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry","volume":"878","author":"Honeywell","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2016.05.001_bb0675","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2011.09.012","article-title":"Development and clinical application of a LC\u2013MS\/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma","volume":"413","author":"G\u00f6tze","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0680","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2013.01.037","article-title":"Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC\/MS\/MS","volume":"926","author":"Andriamanana","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"11\u201312","key":"10.1016\/j.clinbiochem.2016.05.001_bb0685","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cca.2011.02.023","article-title":"Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC\/MS\u2013MS","volume":"412","author":"Bouchet","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0690","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00216-012-5970-2","article-title":"An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography\u2013tandem mass spectrometry","volume":"403","author":"Couchman","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"issue":"19","key":"10.1016\/j.clinbiochem.2016.05.001_bb0695","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jchromb.2011.04.011","article-title":"Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry","volume":"879","author":"Teunissen","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0700","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10549-012-2000-1","article-title":"Importance of highly selective LC\u2013MS\/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen","volume":"133","author":"Jager","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.clinbiochem.2016.05.001_bb0705","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jpba.2011.08.002","article-title":"Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography\/triple\u2013quadrupole mass spectrometry","volume":"56","author":"Binkhorst","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0710","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jchromb.2015.08.025","article-title":"Development and validation of a turbulent flow chromatography and tandem mass spectrometry method for the quantitation of methotrexate and its metabolites 7-hydroxy methotrexate and DAMPA in serum","volume":"1002","author":"Schofield","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0715","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bmc.2741","article-title":"LC\u2013MS\/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients","volume":"27","author":"B\u00fcchel","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"31","key":"10.1016\/j.clinbiochem.2016.05.001_bb0720","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1016\/j.jchromb.2010.10.003","article-title":"A fast and simple assay for busulfan in serum or plasma by liquid chromatography\u2013tandem mass spectrometry using turbulent flow online extraction technology","volume":"878","author":"Bunch","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0725","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3343\/alm.2014.34.1.7","article-title":"Quantification of human plasma-busulfan concentration by liquid chromatography\u2013tandem mass spectrometry","volume":"34","author":"Moon","year":"2014","journal-title":"Ann. Lab. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2016.05.001_bb0730","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/FTD.0000000000000010","article-title":"Rapid and sensitive liquid chromatography coupled with electrospray ionization tandem mass spectrometry method for the analysis of paclitaxel, docetaxel, vinblastine, and vinorelbine in human plasma","volume":"36","author":"Gao","year":"2014","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0735","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpba.2013.12.028","article-title":"LC\u2013MS\/MS quantitative analysis of paclitaxel and its major metabolites in serum, plasma and tissue from women with ovarian cancer after intraperitoneal chemotherapy","volume":"91","author":"Fern\u00e1ndez-Peralbo","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"28","key":"10.1016\/j.clinbiochem.2016.05.001_bb0740","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.jchromb.2011.08.034","article-title":"A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry","volume":"879","author":"Hendrikx","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0745","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpba.2015.08.025","article-title":"Measurement of total and free docetaxel concentration in human plasma by ultra-performance liquid chromatography\u2013tandem mass spectrometry","volume":"117","author":"Rigo-Bonnin","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0750","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/rcm.3938","volume":"23","author":"Damen","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"7","key":"10.1016\/j.clinbiochem.2016.05.001_bb0755","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/1060028014526159","article-title":"Glucarpidase intervention for delayed methotrexate clearance","volume":"48","author":"Cavone","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2012.07.033","article-title":"Liquid chromatography\u2013tandem mass spectrometry method for simultaneous determination of seven commonly used anticancer drugs in human plasma","volume":"906","author":"Zhou","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.clinbiochem.2016.05.001_bb0765","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.talanta.2011.08.034","article-title":"Analysis of anticancer drugs: a review","volume":"85","author":"Nussbaumer","year":"2011","journal-title":"Talanta"},{"issue":"10","key":"10.1016\/j.clinbiochem.2016.05.001_bb0770","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/dta.1781","article-title":"Simultaneous quantification of digoxin, digitoxin, and their metabolites in serum using high performance liquid chromatography\u2013tandem mass spectrometry","volume":"7","author":"Bylda","year":"2015","journal-title":"Drug Test Anal."},{"issue":"10\u201311","key":"10.1016\/j.clinbiochem.2016.05.001_bb0775","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.clinbiochem.2010.04.067","article-title":"Does liquid chromatography\u2013tandem mass spectrometry have a role in therapeutic drug monitoring of digoxin?","volume":"43","author":"Taylor","year":"2010","journal-title":"Clin. Biochem."},{"issue":"9","key":"10.1016\/j.clinbiochem.2016.05.001_bb0780","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/bmc.3437","article-title":"Validation of an ultra-performance liquid chromatography\u2013tandem mass spectrometry method for the determination of flecainide in human plasma and its clinical application","volume":"29","author":"Mano","year":"2015","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0785","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jpba.2009.08.004","article-title":"Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography\u2013tandem mass spectrometry assay","volume":"51","author":"Kuhn","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0790","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpba.2014.08.011","article-title":"Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography\u2013tandem mass spectrometry","volume":"100","author":"Korostelev","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"12","key":"10.1016\/j.clinbiochem.2016.05.001_bb0795","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145478","article-title":"UPLC-MRM mass spectrometry method for measurement of the coagulation inhibitors dabigatran and rivaroxaban in human plasma and its comparison with functional assays","volume":"10","author":"Kuhn","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0800","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-3252-8_3","article-title":"Quantitation of the oral anticoagulants dabigatran, rivaroxaban, apixaban, and warfarin in plasma using ultra-performance liquid chromatography with tandem mass spectrometry (UPLC\u2013MS\/MS)","volume":"1383","author":"Noguez","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2016.05.001_bb0805","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.autrev.2015.05.001","article-title":"New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: a systematic analysis","volume":"14","author":"Meroni","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.clinbiochem.2016.05.001_bb0810","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.intimp.2015.07.007","article-title":"Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC\u2013MS\/MS","volume":"28","author":"Willrich","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2016.05.001_bb0815","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1039\/c2an35082c","article-title":"Rapid analysis of whole blood by paper spray mass spectrometry for point-of-care therapeutic drug monitoring","volume":"137","author":"Espy","year":"2012","journal-title":"Analyst"},{"issue":"3","key":"10.1016\/j.clinbiochem.2016.05.001_bb0820","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1039\/C5AN02302E","article-title":"Therapeutic drug monitoring in dried blood spots using liquid microjunction surface sampling and high resolution mass spectrometry","volume":"141","author":"Gaissmaier","year":"2016","journal-title":"Analyst"},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0825","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2016.01.006","article-title":"Metabolomics: perspectives on potential biomarkers in organ transplantation and immunosuppressant toxicity","volume":"49","author":"Bonneau","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0830","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/clpt.2013.217","article-title":"Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology","volume":"95","author":"Kaddurah-Daouk","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0835","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/cpt.134","article-title":"Metabolomic signatures for drug response phenotypes: pharmacometabolomics enables precision medicine","volume":"98","author":"Kaddurah-Daouk","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0840","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2014.22","article-title":"Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability","volume":"3","author":"Ellero-Simatos","year":"2014","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0845","article-title":"Oxylipid profileof low-dose aspirin exposure: a pharmacometabolomicsstudy","volume":"26","author":"Ellero-Simatos","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.clinbiochem.2016.05.001_bb0850","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17145\/jab.15.008","article-title":"Can pharmacometabolomics and LC-HRMS develop a new concept for therapeutic drug monitoring?","volume":"1","author":"Beck","year":"2015","journal-title":"J. Appl. Bioanal."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0860","unstructured":"Guidance for industry: bioanalytical method validation. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001. Available at: www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070107.pdf. Accessed at March 6., 2016."},{"key":"10.1016\/j.clinbiochem.2016.05.001_bb0870","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/clinchem\/33.3.387","article-title":"Desirable standards of performance for therapeutic drug monitoring","volume":"33","author":"Fraser","year":"1987","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.clinbiochem.2016.05.001_bb0875","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1373\/clinchem.2013.217125","article-title":"Practice-oriented quality specifications for therapeutic drug monitoring","volume":"60","author":"Pauwels","year":"2014","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.clinbiochem.2016.05.001_bb0880","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/cclm-2015-0660","article-title":"Practical approach for medical validation of therapeutic drug monitoring results","volume":"54","author":"Oyaert","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2016.05.001_bb0885","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/FTD.0000000000000089","article-title":"Poor performance of laboratories assaying newly developed antiretroviral agents: results for darunavir, etravirine, and raltegravir from the international quality control program for therapeutic drug monitoring of antiretroviral drugs in human plasma\/serum","volume":"36","author":"Burger","year":"2014","journal-title":"Ther. Drug Monit."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912016300479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912016300479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:50:03Z","timestamp":1757865003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912016300479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":175,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0009912016300479"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.05.001","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC\u2013MS\/MS as a tool for TDM services: Where are we?","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}